Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial
Ericka Berman Posttraumatic Stress Disorder (PTSD) is a debilitating illness affecting approximately 7.8% of people in the U.S. over the course of their lifetime. As of now, two medications are approved in the U.S. to treat PTSD, but both treatments have limited success. Characteristics of the antipsychotic medication quetiapine suggest it may be helpful in treating PTSD symptoms of re-experiencing trauma and hyperarousal. Dr. Gerardo … Continue reading Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial

